Skip to main content

Advertisement

Log in

Urinary Tract Infection in Children

  • Renal (D Noone, Section Editor)
  • Published:
Current Pediatrics Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Urinary tract infections (UTI) are common among children. In the past 20 years, a number of key trials have substantially changed practice, in addition to clarifying the natural history of children managed expectantly. It is now clear that among children with normal kidneys at presentation, chronic kidney disease and hypertension are rare. Improved antenatal ultrasound now detects most significant abnormalities of the kidney and urinary tract, particularly severe hypodysplasia, which is often associated with high-grade vesico-ureteric reflux (VUR). This review aims to summarize the evidence-based treatment of UTI in children.

Recent Findings

There is no difference in symptomatic, microbiologic, or renal outcomes between intravenous and oral antibiotics in treating acute, febrile infection. Long-term antibiotic prophylaxis results in a statistically but not clinically significant reduction in recurrence among young children, with or without VUR. Trials to-date have failed to demonstrate that the surgical correction of VUR confers any additional benefit, which may be because the natural history of VUR is to resolution with time and/or that other factors are more important determinants of outcome.

Summary

A more conservative approach to the management of UTI is warranted for most children. Antibiotic prophylaxis, voiding cystourethrography, and surgery for VUR are not indicated following an initial or infrequent UTI. These measures may have a role in selected subgroups of children at high risk of kidney disease, but this remains a hypothesis pending the results of ongoing trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Hellstrom A, Hanson E, Hansson S, Hjalmas K, Jodal U. Association between urinary symptoms at 7 years old and previous urinary tract infection. Arch Dis Child. 1991;66:232–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Ramirez DC, Courchia B, Roberts KB, Rauch DA. Changes in UTI hospitalizations after the 2011 AAP UTI guidelines. Pediatrics. 2017;140:35.

    Google Scholar 

  3. Lee T, Ellimoottil C, Marchetti KA, Banerjee T, Ivancic V, Kraft KH, et al. Impact of clinical guidelines on voiding cystourethrogram use and vesicoureteral reflux incidence. J Urol. 2017;199:831–6.

    PubMed  Google Scholar 

  4. Tullus K, Jacobson SH, Katouli M, Brauner A. Relative importance of eight virulence characteristics of pyelonephritogenic Escherichia coli strains assessed by multivariate statistical analysis. J Urol. 1991;146:1153–5.

    CAS  PubMed  Google Scholar 

  5. Kudinha T, Johnson JR, Andrew SD, Kong F, Anderson P, Gilbert GL. Genotypic and phenotypic characterization of Escherichia coli isolates from children with urinary tract infection and from healthy carriers. Pediatr Infect Dis J. 2013;32:543–8.

    PubMed  Google Scholar 

  6. Zaffanello M, Malerba G, Cataldi L, Antoniazzi F, Franchini M, Monti E, et al. Genetic risk for recurrent urinary tract infections in humans: a systematic review. J Biomed Biotechnol. 2010;2010:321082.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Jantunen ME, Siitonen A, Ala-Houhala M, Ashorn P, FÖhr A, Koskimies O, et al. Predictive factors associated with significant urinary tract abnormalities in infants with pyelonephritis. Pediatr Infect Dis J. 2001;20:597–601.

    CAS  PubMed  Google Scholar 

  8. Mårild S, Jodal U. Incidence rate of first-time symptomatic urinary tract infection in children under 6 years of age. Acta Paediatr. 2007;87:549–52.

    Google Scholar 

  9. • Montini G, Toffolo A, Zucchetta P, Dall'Amico R, Gobber D, Calderan A, et al. Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial. BMJ. 2007;335:386 Largest RCT (502 children) of oral versus intravenous antibiotics for pyelonephritis in children, demonstrating no difference in symptomatic outcomes or renal scarring.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Singh-Grewal D, Macdessi J, Craig J. Circumcision for the prevention of urinary tract infection in boys: a systematic review of randomised trials and observational studies. Arch Dis Child. 2005;90:853–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Ellison JS, Dy GW, Fu BC, Holt SK, Gore JL, Merguerian PA. Neonatal circumcision and urinary tract infections in infants with hydronephrosis. Pediatrics. 2018;142:e20173703. https://doi.org/10.1542/peds.2017-3703.

    Article  PubMed  Google Scholar 

  12. Le Saux N, Pham B, Moher D. Evaluating the benefits of antimicrobial prophylaxis to prevent urinary tract infections in children: a systematic review. CMAJ. 2000;163:523–9.

    PubMed  PubMed Central  Google Scholar 

  13. Yang S, Chua ME, Bauer S, Wright A, Brandstrom P, Hoebeke P, et al. Diagnosis and management of bladder bowel dysfunction in children with urinary tract infections: a position statement from the international children’s continence society. Pediatr Nephrol. 2017. https://doi.org/10.1007/s00467-017-3799-9.

    PubMed  Google Scholar 

  14. Afshar K, Mirbagheri A, Scott H, MacNeily AE. Development of a symptom score for dysfunctional elimination syndrome. J Urol. 2009;182:1939–43.

    PubMed  Google Scholar 

  15. Keren R, Shaikh N, Pohl H, Gravens-Mueller L, Ivanova A, Zaoutis L, et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics. 2015;136:e13–21.

    PubMed  PubMed Central  Google Scholar 

  16. Sillen U, Brandstrom P, Jodal U, Holmdahl G, Sandin A, Sjoberg I, et al. The Swedish reflux trial in children: v. Bladder dysfunction. J Urol. 2010;184:298–304.

    PubMed  Google Scholar 

  17. Shaikh N, Ewing AL, Bhatnagar S, Hoberman A. Risk of renal scarring in children with a first urinary tract infection: a systematic review. Pediatrics. 2010;126:1084–91.

    PubMed  Google Scholar 

  18. Shaikh N, Craig JC, Rovers MM, Da Dalt L, Gardikis S, Hoberman A, et al. Identification of children and adolescents at risk for renal scarring after a first urinary tract infection: a meta-analysis with individual patient data. JAMA Pediatr. 2014;168:893–900.

    PubMed  Google Scholar 

  19. Shaikh N, Hoberman A, Keren R, Gotman N, Docimo SG, Mathews R, et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics. 2016;137:e20152982.

    PubMed Central  Google Scholar 

  20. • Craig JC, Simpson JM, Williams GJ, Lowe A, Reynolds GJ, McTaggart SJ, et al. Antibiotic prophylaxis and recurrent urinary tract infection in children. New Engl J Med. 2009;361:1748–59 First placebo-controlled trial of antibiotic prophylaxis following UTI in children, found that 14 patient-years of antibiotics required to prevent one child experiences recurrence.

    CAS  PubMed  Google Scholar 

  21. Panaretto KS, Craig JC, Knight JF, Howman-Giles R, Sureshkumar P, Roy LP. Risk factors for recurrent urinary tract infection in preschool children. J Paediatr Child Health. 1999;35:454–9.

    CAS  PubMed  Google Scholar 

  22. • Hoberman A, Greenfield SP, Mattoo TK, Keren R, Mathews R, Pohl HG, et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New Engl J Med. 2014;370:2367–76 This RCT confirms the results of an earlier trial by Craig et al 2009 among a group of 607 children with confirmed VUR diganosed following a first or second UTI, finding only a small risk reduction with antibiotic prophylaxis (NNT 16 patient-years of antibiotics to prevent one UTI, 22 patient-years to prevent one febrile UTI).

    PubMed  Google Scholar 

  23. Shaikh N, Mattoo TK, Keren R, Ivanova A, Cui G, Moxey-Mims M, et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatr. 2016;120:e922–e8.

    Google Scholar 

  24. Toffolo A, Ammenti A, Montini G. Long-term clinical consequences of urinary tract infections during childhood: a review. Acta Paediatr. 2012;101:1018–31.

    PubMed  Google Scholar 

  25. Craig JC, PhD E, Irwig LM, PhD F, Knight JF, Roy LP. Does treatment of vesicoureteric reflux in childhood prevent end-stage renal disease attributable to reflux nephropathy? Pediatrics. 2000;105:1236–41.

    CAS  PubMed  Google Scholar 

  26. Clayton P, Hurst K. ANZDATA registry report 2016. http://www.anzdata.org.au/v1/report_2016.html. Accessed 31 Oct 2018.

  27. Silva JMP, Santos Diniz JS, Marino VSP, Lima EM, Cardoso LSB, Vasconcelos MA, et al. Clinical course of 735 children and adolescents with primary vesicoureteral reflux. Pediatr Nephrol. 2006;21:981–8.

    PubMed  Google Scholar 

  28. Montini G, Tullus K, Hewitt I. Febrile urinary tract infections in children. New Engl J Med. 2011;365:239–50.

    CAS  PubMed  Google Scholar 

  29. Ardissino G, Dacco V, Testa S, Bonaudo R, Claris-Appiani A, Taioli E, et al. Epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics. 2003;111:e382–7.

    PubMed  Google Scholar 

  30. Pope J, Brock J, Adams M, Stephens F, Ichikawa I. How they begin and how they end classic and new theories for the development and deterioration of congenital anomalies of the kidney and urinary tract, CAKUT. J Am Soc Nephrol. 1999;10:2018–28.

    PubMed  Google Scholar 

  31. van der Ven AT, Vivante A, Hildebrandt F. Novel insights into the pathogenesis of monogenic congenital anomalies of the kidney and urinary tract. J Am Soc Nephrol. 2018;29:36–50.

    PubMed  Google Scholar 

  32. Cardiff-Oxford Bacteriuria Study Group. Sequalae of covert bacteriuria in schoolgirls: a four-year follow-up study. Lancet. 1978;311:889–93.

    Google Scholar 

  33. Verrier Jones K, Asscher AW, Verrier Jones ER, Mattholie K, Leach K, Thomson GM. Glomerular filtration rate in schoolgirls with covert bacteriuria. BMJ. 1982;285:1307–10.

    CAS  PubMed  Google Scholar 

  34. Wettergren B, Hellström M, Stokland E, Jodal U. Six year follow up of infants with bacteriuria on screening. BMJ. 1990;301:845–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Al-Orifi F, McGillivray D, Tange S, Kramer MS. Urine culture from bag specimens in young children: are the risks too high? J Pediatr. 2000;137:221–6.

    CAS  PubMed  Google Scholar 

  36. McGillivray D, Mok E, Mulrooney E, Kramer MS. A head-to-head comparison: “clean-void” bag versus catheter urinalysis in the diagnosis of urinary tract infection in young children. J Pediatr. 2005;147:451–6.

    PubMed  Google Scholar 

  37. Williams G, Sureshkumar P, Caldwell P, Craig JC. Urinary tract infection, vesicoureteric reflux, and urinary incontinence. In: Molony DA, Craig JC, editors. Evidence-based nephrology. Hoboken: Wiley; 2008. p. 745–62.

    Google Scholar 

  38. Kaufman J, Fitzpatrick P, Tosif S, Hopper SM, Donath SM, Bryant PA, et al. Faster clean catch urine collection (quick-wee method) from infants: randomised controlled trial. BMJ. 2017;357:j1341.

    PubMed  Google Scholar 

  39. Kanegaye JT, Jacob JM, Malicki D. Automated urinalysis and urine dipstick in the emergency evaluation of young febrile children. Pediatrics. 2014;124:523–9.

    Google Scholar 

  40. Tzimenatos L, Mahajan P, Dayan PS, Vitale M, Linakis JG, Blumberg S, et al. Accuracy of the urinalysis for urinary tract infections in febrile infants 60 days and younger. Pediatrics. 2018;141:e20173068.

    PubMed  Google Scholar 

  41. Schroeder AR, Chang PW, Shen MW, Biondi EA, Greenhow TL. diagnostic accuracy of the urinalysis for urinary tract infection in infants <3 months of age. Pediatrics. 2015;135:965–71.

    PubMed  Google Scholar 

  42. Williams GJ, Macaskill P, Chan SF, Turner RM, Hodson E, Craig JC. Absolute and relative accuracy of rapid urine tests for urinary tract infection in children: a meta-analysis. Lancet Infect Dis. 2010;10:240–50.

    PubMed  Google Scholar 

  43. Valdimarsson S, Jodal U, Barregard L, Hansson S. Urine neutrophil gelatinase-associated lipocalin and other biomarkers in infants with urinary tract infection and in febrile controls. Pediatr Nephrol. 2017;32:2079–87.

    PubMed  Google Scholar 

  44. Schroeder AR. UTI and Faulty Gold Standards. Pediatrics. 2017;139(3):03.

    PubMed  Google Scholar 

  45. Mori R, Yonemoto N, Fitzgerald A, Tullus K, Verrier-Jones K, Lakhanpaul M. Diagnostic performance of urine dipstick testing in children with suspected UTI: a systematic review of relationship with age and comparison with microscopy. Acta Paediatr. 2010;99:581–4.

    CAS  PubMed  Google Scholar 

  46. Benador D, Neuhaus TJ, Papazyan JP, Willi UV, Engel-Bicik I, Nadal D, et al. Randomised controlled trial of three day versus 10 day intravenous antibiotics in acute pyelonephritis: effect on renal scarring. Arch Dis Child. 2001;84:241–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Bouissou F, Munzer C, Decramer S, Roussel B, Novo R, Morin D, et al. Prospective, randomized trial comparing short and long intravenous antibiotic treatment of acute pyelonephritis in children: dimercaptosuccinic acid scintigraphic evaluation at 9 months. Pediatrics. 2008;121:e553–60.

    PubMed  Google Scholar 

  48. Vilaichone A, Watana D, Chaiwatanarat T. Oral ceftibuten switch therapy for acute pyelonephritis in children. J Med Assoc Thail. 2001;84:S61–7.

    Google Scholar 

  49. Hoberman A, Wald ER, Hickey RW, Baskin M, Charron M, Majd M, et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics. 1999;104:79–86.

    CAS  PubMed  Google Scholar 

  50. Strohmeier Y, Hodson EM, Willis NS, Webster AC, Craig JC. Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev. 2014;(7):CD003772. https://doi.org/10.1002/14651858.CD003772.pub3.

  51. Mori R, Lakhanpaul M, Verrier-Jones K. Diagnosis and management of urinary tract infection in children: summary of NICE guidance. BMJ. 2007;335:395–7.

    PubMed  PubMed Central  Google Scholar 

  52. Baker PC, Nelson DS, Schunk JE. The addition of ceftriaxone to oral therapy does not improve outcome in febrile children with urinary tract infections. Arch Pediatr Adolesc Med. 2001;155:135–9.

    CAS  PubMed  Google Scholar 

  53. Bergeron MG, Marois Y. Benefit from high intrarenal levels of gentamicin in the treatment of E. coli pyelonephritis. Kidney Int. 1986;30:481–7.

    CAS  PubMed  Google Scholar 

  54. Bitsori M, Maraki S, Galanakis E. Long-term resistance trends of uropathogens and association with antimicrobial prophylaxis. Pediatr Nephrol. 2014;29:1053–8.

    PubMed  Google Scholar 

  55. Bryce A, Hay AD, Lane IF, Thornton HV, Wootton M, Costelloe C. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis. BMJ. 2016;352:i939.

    PubMed  PubMed Central  Google Scholar 

  56. Raman G, McMullan B, Taylor P, Mallitt KA, Kennedy SE. Multiresistant E. coli urine infections in children: a case-control study. Arch Dis Child. 2018;103:336–40.

    PubMed  Google Scholar 

  57. Fitzgerald A, Mori R, Lakhanpaul M, Tullus K. Antibiotics for treating lower urinary tract infection in children. Cochrane Database Syst Rev. 2012;(8):CD006857.

  58. Abrahamsson K, Hansson S, Larsson P, Jodal U. Antibiotic treatment for five days is effective in children with acute cystitis. Acta Paediatr. 2007;91:55–8.

    Google Scholar 

  59. Tran D, Muchant DG, Aronoff SC. Short-course versus conventional length antimicrobial therapy for uncomplicated lower urinary tract infections in children: a meta-analysis of 1279 patients. J Pediatr. 2001;139:93–9.

    CAS  PubMed  Google Scholar 

  60. Kronenberg A, Butikofer L, Odutayo A, Muhlemann K, da Costa BR, Battaglia M, et al. Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial. BMJ. 2017;359:j4784.

    PubMed  PubMed Central  Google Scholar 

  61. Gagyor I, Bleidorn J, Kochen MM, Schmiemann G, Wegscheider K, Hummers-Pradier E. Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial. BMJ. 2015;351:h6544.

    PubMed  PubMed Central  Google Scholar 

  62. Garin EH, Olavarria F, Nieto VG, Valenciano B, Campos A, Young L. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics. 2006;117:626–32.

    PubMed  Google Scholar 

  63. Roussey-Kesler G, Gadjos V, Idres N, Horen B, Ichay L, Leclair M, et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. J Urol. 2008;179:674–9.

    CAS  PubMed  Google Scholar 

  64. Pennesi M, Travan L, Peratoner L, Bordugo A, Cattaneo A, Ronfani L, et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics. 2008;121:e1489–e94.

    PubMed  Google Scholar 

  65. Montini G, Rigon L, Zucchetta P, Fregonese F, Toffolo A, Gobber D, et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics. 2008;122:1064–71.

    PubMed  Google Scholar 

  66. Hewitt I, Dall’Amico R, Montini G. Antimicrobial prophylaxis for children with vesicoureteral reflux. New Engl J Med. 2014;371:1071.

    PubMed  Google Scholar 

  67. Brandstrom P, Esbjorner E, Herthelius M, Holmdahl G, Lackgren G, Neveus T, et al. The Swedish reflux trial in children: I. Study design and study population characteristics. J Urol. 2010;184:274–9.

    PubMed  Google Scholar 

  68. Hewitt IK, Pennesi M, Morello W, Ronfani L, Montini G. Antibiotic prophylaxis for urinary tract infection–related renal scarring: a systematic review. Pediatrics. 2017;139:e20163145.

    PubMed  Google Scholar 

  69. Ammenti A, Cataldi L, Chimenz R, Fanos V, La Manna A, Marra G, et al. Febrile urinary tract infections in young children: recommendations for the diagnosis, treatment and follow-up. Acta Paediatr. 2012;101:451–7.

    PubMed  Google Scholar 

  70. Caljouw MAA, van den Hout WB, Putter H, Achterberg WP, Cools HJM, Gussekloo J. Effectiveness of cranberry capsules to prevent urinary tract infections in vulnerable older persons: a double-blind randomized placebo-controlled trial in long-term care facilities. J Am Geriatr Soc. 2014;62:103–10.

    PubMed  Google Scholar 

  71. Barbosa-Cesnik C, Brown MB, Buxton M, Zhang L, DeBusscher J, Foxman B. Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial. Clin Infect Dis. 2011;52:23–30.

    PubMed  PubMed Central  Google Scholar 

  72. Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;(10):CD001321. https://doi.org/10.1002/14651858.CD001321.pub4

  73. Luis A, Domingues F, Pereira L. Can cranberries contribute to reduce the incidence of urinary tract infections? A systematic review with meta-analysis and trial sequential analysis of clinical trials. J Urol. 2017;198:614–21.

    PubMed  Google Scholar 

  74. Schwenger EM, Tejani AM, Loewen PS. Probiotics for preventing urinary tract infections in adults and children. Cochrane Database Syst Rev. 2015;(12):CD008772.

  75. Lee SJ, Lee JW. Probiotics prophylaxis in infants with primary vesicoureteral reflux. Pediatr Nephrol. 2015;20:209–13.

    Google Scholar 

  76. Smellie JM, Tamminen-Mobius T, Olbing H, Claesson I, Wikstad I, Jodal U, et al. Five-year study of medical or surgical treatment in children with severe reflux: radiological renal findings. Pediatr Nephrol. 1992;6:223–30.

    CAS  PubMed  Google Scholar 

  77. Jodal U, Koskimies O, Hanson E, Löhr G, Olbing H, Smellie J, et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long-term antibacterial prophylaxis. J Urol. 1992;148:1650–2.

    CAS  PubMed  Google Scholar 

  78. Smellie JM, Barratt TM, Chantler C, Gordon I, Prescod NP, Ransley PG, et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet. 2001;357:1329–33.

    CAS  PubMed  Google Scholar 

  79. Brandstrom P, Esbjorner E, Herthelius M, Swerkersson S, Jodal U, Hansson S. The Swedish reflux trial in children: III. Urinary tract infection pattern. J Urol. 2010;184:286–91.

    PubMed  Google Scholar 

  80. Brandstrom P, Jodal U, Sillen U, Hansson S. The Swedish reflux trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. J Pediatr Urol. 2011;7:594–600.

    PubMed  Google Scholar 

  81. Holmdahl G, Brandstrom P, Lackgren G, Sillen U, Stokland E, Jodal U, et al. The Swedish reflux trial in children: II. Vesicoureteral reflux outcome. J Urol. 2010;184:280–5.

    PubMed  Google Scholar 

  82. Wiener JS, Scales MT, Hampton J, King LR, Surwit R, Edwards CL. Long-term efficacy of simple behavioral therapy for daytime wetting in children. J Urol. 2000;164:786–90.

    CAS  PubMed  Google Scholar 

  83. van Gool JD, de Jong TP, Winkler-Seinstra P, Tamminen-Mobius T, Lax H, Hirche H, et al. Multi-center randomized controlled trial of cognitive treatment, placebo, oxybutynin, bladder training, and pelvic floor training in children with functional urinary incontinence. Neurourol Urodyn. 2014;33:482–7.

    PubMed  Google Scholar 

  84. Altan M, Citamak B, Bozaci AC, Mammadov E, Dogan HS, Tekgul S. Is there any difference between questionnaires on pediatric lower urinary tract dysfunction? Urology. 2017;103:204–8.

    PubMed  Google Scholar 

  85. Montini G, Zucchetta P, Tomasi L, Talenti E, Rigamonti W, Picco G, et al. Value of imaging studies after a first febrile urinary tract infection in young children: data from Italian renal infection study 1. Pediatrics. 2009;123:e239–46.

    PubMed  Google Scholar 

  86. McTaggart S, Danchin M, Ditchfield M, Hewitt I, Kausman J, Kennedy S, et al. KHA-CARI guideline: diagnosis and treatment of urinary tract infection in children. Nephrology. 2015;20:55–60.

    PubMed  Google Scholar 

  87. Subcommittee On Urinary Tract Infections. Reaffirmation of AAP clinical practice guideline: the diagnosis and management of the initial urinary tract infection in febrile infants and young children 2–24 months of age. Pediatrics. 2016;138:e20163026.

    Google Scholar 

  88. Robinson JL, Finlay JC, Lang ME, Bortolussi R. Urinary tract infections in infants and children: diagnosis and management. Paediatr Child Health. 2014;19:315–9.

    PubMed  PubMed Central  Google Scholar 

  89. NICE. Urinary tract infection in under 16s: diagnosis and management. 2017. http://www.nice.org.uk/guidance/CG54. Accessed 4 Sept 2019.

  90. Pauchard JY, Chehade H, Kies CZ, Girardin E, Cachat F, Gehri M. Avoidance of voiding cystourethrography in infants younger than 3 months with Escherichia coli urinary tract infection and normal renal ultrasound. Arch Dis Child. 2017;102:804–8.

    PubMed  Google Scholar 

  91. Marks SD, Gordon I, Tullus K. Imaging in childhood urinary tract infections: time to reduce investigations. Pediatr Nephrol. 2008;23:9–17.

    PubMed  Google Scholar 

  92. De Sadeleer C, De Boe V, Keuppens F, Desprechins B, Verboven M, Piepsz A. How good is technetium-99m mercaptoacetyltriglycine indirect cystography? Eur J Nucl Med. 1994;21:223–7.

    PubMed  Google Scholar 

  93. Hansson S, Dhamey M, Sigstrom O, Sixt R, Stokland E, Wennerstrom M, et al. Dimercapto-succinic acid scintigraphy instead of voiding cystourethrography for infants with urinary tract infection. J Urol. 2004;172:1071–3.

    PubMed  Google Scholar 

  94. Lee HY, Soh BH, Hong CH, Kim MJ, Han SW. The efficacy of ultrasound and dimercaptosuccinic acid scan in predicting vesicoureteral reflux in children below the age of 2 years with their first febrile urinary tract infection. Pediatr Nephrol. 2009;24:2009–13.

    PubMed  Google Scholar 

  95. De Palma D, Manzoni G. Different imaging strategies in febrile urinary tract infection in childhood. What, when, why? Pediatr Radiol. 2013;43:436–43.

    PubMed  Google Scholar 

  96. La Scola C, De Mutiis C, Hewitt IK, Puccio G, Toffolo A, Zucchetta P, et al. Different guidelines for imaging after first UTI in febrile infants: yield, cost, and radiation. Pediatrics. 2013;131:e665–71.

    PubMed  Google Scholar 

  97. Daniel M, Szajewska H, Panczyk-Tomaszewska M. 7-day compared with 10-day antibiotic treatment for febrile urinary tract infections in children: protocol of a randomised controlled trial. BMJ Open. 2018;8:e019479.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ian K. Hewitt.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Renal

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Larkins, N.G., Hewitt, I.K. Urinary Tract Infection in Children. Curr Pediatr Rep 6, 259–268 (2018). https://doi.org/10.1007/s40124-018-0181-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40124-018-0181-8

Keywords

Navigation